CLINICAL TRIALS PROFILE FOR OMECAMTIV MECARBIL
✉ Email this page to a colleague
Clinical Trials for Omecamtiv mecarbil
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT00682565 ↗ | PK and Tolerability of IV and Oral CK-1827452 in Patients With Ischemic Cardiomyopathy and Angina | Completed | Cytokinetics | Phase 2 | This study investigates whether symptom-limited exercise capacity in ischemic cardiomyopathy patients with angina is deleteriously affected by treatment with CK-1827452. |
NCT01077167 ↗ | Pharmacokinetic Study of Omecamtiv Mecarbil in Heart Failure Patients | Withdrawn | Amgen | Phase 2 | The purpose of this trial is to obtain a pharmacokinetic profile (i.e. amount of drug in the blood over time) of Omecamtiv mecarbil in patients with stable heart failure. |
NCT01077167 ↗ | Pharmacokinetic Study of Omecamtiv Mecarbil in Heart Failure Patients | Withdrawn | Cytokinetics | Phase 2 | The purpose of this trial is to obtain a pharmacokinetic profile (i.e. amount of drug in the blood over time) of Omecamtiv mecarbil in patients with stable heart failure. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Omecamtiv mecarbil
Condition Name
Clinical Trial Locations for Omecamtiv mecarbil
Trials by Country
Clinical Trial Progress for Omecamtiv mecarbil
Clinical Trial Phase
Clinical Trial Sponsors for Omecamtiv mecarbil
Sponsor Name